PMV Pharmaceuticals
Presencia
PMV Pharmaceuticals es una de las ...
PMV Pharmaceuticals es una empresa que cotiza bajo el símbolo de cotización PMVP (US).
Ejecutivos
Ver el organigrama con sus 19 ejecutivos principales
Biografías más buscadas en PMV Pharmaceuticals
- David Mack, Director, President and Chief Executive Officer
- Arnold Levine, Director
- Kirsten Flowers, Director
Recientes movimientos de ejecutivos en PMV Pharmaceuticals
- Leila Alland, Chief Medical Officer, ha dejado la empresa (noticia publicada el 21 de enero de 2024).
- Winston Kung, Chief Operating Officer and Chief Financial Officer, ha dejado la empresa (noticia publicada el 8 de enero de 2024).
- Michael Carulli que ha sido Senior Vice President, Finance, ha ascendido a Chief Financial Officer (noticia publicada el 8 de enero de 2024).
Crear su alerta
para seguir los movimientos de los ejecutivos en PMV Pharmaceuticals.
Farmacia
PMV Pharmaceuticals tiene 1.860 competidores entre los que se incluyen Pfizer (Estados Unidos), Sanofi (Francia) y Johnson & Johnson (Estados Unidos).
Popular M&A news in Farmacia
- MedMen has filed for bankruptcy protection (publicado el 28 de abril de 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (publicado el 23 de marzo de 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (publicado el 19 de marzo de 2024).
Otros contactos sugeridos en el sector Farmacia
Noticias
Últimos comunicados de prensa de PMV Pharmaceuticals
- PMV Pharmaceuticals Announces a Clinical Trial Collaboration with Merck to Evaluate PC14586 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced Solid Tumors | PMV Pharmaceuticals, Inc.
- PMV Pharmaceuticals to Participate in the Goldman Sachs Global Healthcare Conference | PMV Pharmaceuticals, Inc.
- PMV Pharmaceuticals Initial PC14586 Phase 1 Data Presented at ASCO Demonstrated Anti-Tumor Activity Across Multiple Solid Tumor Types With a p53 Y220C Mutation | PMV Pharmaceuticals, Inc.
- PMV Pharmaceuticals Announces Initial PC14586 Phase 1 Clinical Data to be Presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting | PMV Pharmaceuticals, Inc.
- PMV Pharmaceuticals Reports First Quarter 2022 Financial Results and Corporate Highlights | PMV Pharmaceuticals, Inc.
- PMV Pharmaceuticals to Present PC14586 Phase 1 Clinical Data at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting | PMV Pharmaceuticals, Inc.
- PMV Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Highlights | PMV Pharmaceuticals, Inc.
- PMV Pharmaceuticals to Participate in the 42nd Annual Cowen Health Care Conference | PMV Pharmaceuticals, Inc.
- PMV Pharmaceuticals to Participate in the Guggenheim Healthcare Talks 2022 Oncology Day | PMV Pharmaceuticals, Inc.
- PMV Pharma Announces Changes to its Board of Directors | PMV Pharmaceuticals, Inc.
- View more press releases Close
Redes sociales sobre PMV Pharmaceuticals
- PMV Pharmaceuticals en Wikipedia, Google News y Yahoo Finance
- PMV Pharmaceuticals en LinkedIn, Twitter y YouTube
Ponerse en contacto
Contactar a través de e-mail con sus ejecutivos David Mack 
Llame a PMV Pharmaceuticals al +1 609...
